---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-152363"
form_type: "8-K"
ticker: "SNSE"
cik: "0001829802"
company_name: "Sensei Biotherapeutics, Inc."
filed_at: "2024-06-03T23:59:59+00:00"
generated_at: "2026-06-01T06:53:50.145671+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Sensei Biotherapeutics updates corporate presentation for investor meetings

## Summary
- Filed an updated corporate presentation on June 3, 2024 under Regulation FD.
- Presentation used in meetings with investors but no specific new data disclosed.
- No financial results, pipeline updates, or clinical milestones included in the filing.

## SEC filing metadata
- accession: 0001193125-24-152363
- form_type: 8-K
- ticker: SNSE
- cik: 0001829802
- company_name: Sensei Biotherapeutics, Inc.
- filed_at: 2024-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829802/000119312524152363/0001193125-24-152363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829802/000119312524152363/d845171d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-152363
- JSON: https://secwatch.observer/filing/0001193125-24-152363.json
- Plain text: https://secwatch.observer/filing/0001193125-24-152363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.